The biosynthetic shikimate pathway of M. tuberculosisis is essential for synthesis of aromatic amino acids. The reaction catalyzed by Mycobacterium tuberculosis shikimate kinase (MtSK) is the fifth step of the shikimate pathway that is present in plants, fungi and bacteria but not in humans representing a promising drug target [1] . Plasmodium falciparum thioredoxin reductase (PfTrxR), an enzyme needed to maintain redox homeostasis in Plasmodium species, represents a potential target for new antimalarials. Essential oils (EOs) and their constituents are commonly known for their antibacterial and antiplasmodial activity [2, 3a] , and some EOs have reported activity against M. tuberculosis [3b]. Santalum album L., belongs to the family Santalaceae that has originally been grown in India and highly admired for its medicinally valued fragrant oil named East Indian Sandalwood oil (EISO) [3c] . Approximately 90% of EISO is composed of the sesquiterpene alcohols -santalol, -santalol, epi--santalol and trans--bergamotol with -and -santalol concentration more than 50% [4] . Modern pharmacological studies have demonstrated its wide range of pharmacological activities including antibacterial and antiplasmodial effects with its substantial therapeutic importance being assigned to the high content of phytochemicals most of which are sesquiterpenes [5a,b]. The antiplasmodial activity of EISO has previously been examined by Fujisaki et al. where IC 50 of 1 µg/mL was found for its in vitro antiplasmodial activity in a cell culture with P. falciparum FCR-3/Gambia. However, in the same study, EISO did not show antiplasmodial activity when administerd orally, intraperitoneally or intravenously in the in vivo analysis utilizing a rodent model. Notably, their in vivo analysis showed antiplasmodial activity with EISO subcutaneous administration [5a]. Based on the antibacterial and antiplasmodial activities reported, we decided to test EISO on the promising targets MtSK and PfTrxR. Non-polar samples like essential oils can be solubilized in detergents when studied in biological assays. However, a surfactant concentration in the assay should be very limited so as to avoid compromising essential oil's biological activity or exaggerated activity resulting from a surfactant [5c]. Tween ® -20 has been recognized as a best surfactant in solubilization of essential oils and having less antimicrobial activity than other detergents [6a]. Samples in non-volatile assay buffers and detergents are often cleaned before LC-MS analysis because these usually cause signal suppression and ionization interferences. Solid-phase extraction (SPE) has successfully been used in sample cleaning prior to chromatographic analysis. The two SPE resources Bond Elut Omix C18 tips and TARGA C18 macroSpin TM SMM columns are used for detergent and salt removal from proteins and small molecules respectively [6b,c]. EISO has shown activity against both Gram-positive and Gram-negative bacteria [5b]. However, its antimycobacterial activity has not been studied. Although EISO has shown antiplasmodial activity, its mechanism of action was unknown. The goal of this study was to screen EISO for antimycobacterial activity through MtSK inhibition and antiplasmodial activity by PfTrxR inhibition.In the in vitro antitubercular screening, EISO was active against Mtb H 37 Rv (wild type) strain with MIC values of 0.002 % v/v (Table 1) . Cytotoxity for EISO was previously studied on mammalian Vero cells with reported IC 50 of 60 µg/mL [7] . Using the reported cytotoxic IC 50 and the acquired MIC value of 0.002% v/v gives the selectivity index (SI) value of 30 for EISO. This suggests that EISO is nontoxic to mammalian cells at the used concentration because the obtained SI > 9 based on criterion described by Ananthan et al. [8a] . A positive control (ethambutol) displayed an MIC value of 0.5 µg/mL. Based on these, the test concentration for preliminary MtSK screening of EISO on the functional assay was carried out at concentration 5 times higher (0.01% v/v) than the EISO's MIC (0.002% v/v).
Subsequently, preliminary screening of EISO showed 53% MtSK inhibitory activity at 0.01% v/v in the 30 min pre-incubation assay. However, preliminary screening of EISO only showed 27% MtSK inhibition in the assay without pre-incubation. This shows that pre-incubation is required for EISO to exert its inhibitory activity in the MtSK assay which suggests irreversible inhibition. Since >50% inhibition was obtained in the 30 min pre-incubation assay, IC 50 determination was then conducted with 10-fold increasing The test concentration for PfTrxR preliminary screening of EISO (0.01% v/v) was chosen based on its reported antiplasmodial activity IC 50 of 1 µg/mL [5a]. EISO at this concentration in the preliminary screening showed 90% PfTrxR inhibition. Extracted ion chromatograms (EICs) of the end-product Trx-(SH) 2 were overlaid and compared to display Trx-(SH) 2 suppression in the presence of EISO to assess inhibition ( Figure 2 ). The quality of the MtSK and PfTrxR screening assays was consistent with the inhibitory activity of previously described reference compounds [1, 8b] . Even though EISO dissolved in DMSO could not stay in solution in the LC-MSbased assay buffers, a surfactant Tween ® -20 diluted to 0.02% v/v was sufficient to keep it well dispersed in buffer except at concentrations above 0.05% v/v. The use of Tween ® -20 did not show any activity against MtSK and PfTrxR at the concentration used. EISO is mainly composed of sesquiterpenes of which (Z)--santalol is a major constituent, however, it is a complex mixture of other compounds including alcohols, santalic acids, aldehydes and ketones [9] . Based on the available data, it is not clear whether the observed activities are from the individual components or a synergy from various constituents [10a] . However, in the reported colorimetric study, EISO showed the potent inhibition of both tyrosinase (IC 50 , 171 μg/mL) and cholinesterases (IC 50 , 4.8 μg/mL (acetylcholinesterase inhibition) and 58 μg/mL (butyrylcholinesterase inhibition)) and a subsequent thin layer chromatography (TLC)-bioautographic assay identified the major sandalwood oil constituent, α-santalol, as a strong inhibitor of both tyrosinase and cholinesterase [10b] . Furthermore, in the investigation of Eastern Polynesian sandalwood oil as a less expensive potential substitute of EISO [11], the close relationship between the two sandalwood oils was confirmed. Both the chemical composition and odor impression of Eastern Polynesian sandalwood oil resembled those of EISO. Gas chromatography-mass spectrometry (GC-MS) analysis of Eastern Polynesian sandalwood oil reported the main constituents (Z)-α-santalol (39.1-48.7%) and (Z)-β-santalol (16.9-19.9%) comparative to those of EISO ((Z)-α-santalol, 47.8% and (Z)-β-santalol, 20.6%).
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We report for the first time the inhibitory activity of EISO on MtSK and PfTrxR. This study also reports the Mtb H37Rv growth inhibition by EISO. While EISO showed both MtSK inhibition and Mtb wild type (H37Rv) growth inhibition, there is no direct indication in this study that only MtSK inhibition accounts for the antitubercular mechanism of EISO. Furthermore, the PfTrxR inhibition found in this study may not directly explain the antiplasmodial activity of EISO reported in the literature. Instead, this study suggests MtSK and PfTrxR inhibition as potential mechanisms for antitubercular and antiplasmodial activies of EISO. , 59 kDa) enzyme was a kind gift from Prof. Katja Becker, Justus-Liebig University, Giessen, Germany. The recombinant PfTrxR was prepared and purified using silver-stained sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS-PAGE) procedure [12a]. The specific activity of PfTrxR (1.9 U/mg) was determined by DTNB [5,5-dithiobis(2-nitrobenzoic acid)]. The protein concentration of enzyme was determined by the Bradford protein assay [12b] . Confirmation of the enzyme purity (>95%) was done using the mass spectrometry the activity was 19 U/mg as measured by a coupled spectrophotometric enzymatic assay. Bond Elut Omix pipette tips were purchased from Agilent Technologies (Santa Clara, CA, USA). TARGA C18 macroSpin TM columns (p/n: SMM SS18R) were bought from The Nest Group, Inc. (Southborough, MA). The well characterized East Indian sandalwood oil (EISO) by GC/FID analysis containing α-santalol (47.8%), β-santalol (20.6%), epi--santalol (4.4%) and trans--bergamotol (6.0%) was kindly supplied by Santalis Pharmaceuticals (San Antonio, TX, USA). MtSK inhibitory activity of East Indian sandalwood oil Natural Product Communications Vol. 12 (9) 2017 1493 microtiter plate. The assay plates also contained uninoculated drug, medium controls and viability controls. 200 µL of EISO was mixed with 100 µL of DMSO and then combined with 4.7 mL of 0.01% Tween ® -80 in Middlebrook 7H12 broth. The resulting solution was composed of 4% EISO and 1% DMSO. Once the compound was assayed, the concentrations of EISO and DMSO were 2% and 1% respectively. DMSO and Tween ® -80 did not affect the bacterial growth at the used concentrations. Plates were transferred into the BSL3 facility for bacteria addition and incubation. Each plate was then inoculated with 0.05 mL of standardized culture and all were incubated at 37°C for 6 days. The REDOX indicator Alamar Blue (Acumed International, Inc., Westlake, Ohio) was then added to each well as a mixture with Tween 80, and the plates were incubated for an additional 18 to 22 h. The plates were read in an optical microtiter plate reader programmed to subtract the absorbance at 600 nm from that at 570 nm to blank out turbidity and absorbance due to oxidized dye. The MIC was defined as the lowest concentration of drug that inhibited visual growth of the test organism and yields a differential absorbance of zero or less. This approximated the color change of blue to red that was observed visually after metabolic reduction of dyes and represented the concentration at which no visible growth occurred. Ethambutol (Sigma, St Louis, MO, USA) was used as a positive control.
Experimental

Growth conditions and media used in the Minimum
Selection of testing concentration and sample preparation:
Selection of concentration for the EISO preliminary screening in the MtSK assay was based on the MIC values from the Mtb cell culture study. In this study, EISO was active against wild type strain of M. tuberculosis (Mtb H 37 Rv) showing the bacterial growth inhibition at MIC value of 0.002% v/v. The concentration for preliminary MtSK screening of EISO on the functional assay was then chosen to be at concentration 5 times higher (0.01%) than the EISO's MIC (0.002% v/v). Once the activity was obtained (>50% inhibition), the IC 50 determination was then conducted with 10-fold increasing EISO concentrations that enclose both the Mtb cell culture MIC and the initial screening concentrations (0.0004% -0.05% v/v). EISO has been stated to have an IC 50 value of 1 µg/mL against P. falciparum FCR-3/Gambia [5a]. Given this, EISO was preliminarily tested at a concentration of 0.01% v/v for PfTrxR inhibition. EISO dissolved in dimethylsulfoxide (DMSO) could not stay in solution in the LC-MS-based assay buffers indicating a need to use a detergent. EISO at concentration of 0.5% v/v stock solution was prepared in 0.02% Tween ® -20. Working solutions at concentrations 0.01%, 0.05% and 0.1% v/v in both MtSK and PfTrxR buffers were prepared and studied under a Dynamic Light Scattering (DLS) system (PSS-NICOMP 380 ZLS, Santa Barbara, CA) to determine the concentration at which EISO is soluble in the assay buffers and at what concentration it starts to form aggregates due to insolubility. This was carried out based on the principle that most small molecules exhibit aggregation leading to false positive results resulting from nonspecific attachment to target proteins in many screening bioassays [13] . It is generally considered that DLS variance (Polydispersity Index (PI)) less than 0.7 resembles sample uniformity [14] . Highest EISO concentration to be used in these assays was found as 0.05% v/v where PI was 0.557 with particle mean diameter of 353 nm. To confirm that there is no aggregation below this concentration, 0.01% v/v EISO DLS study gave a PI of 0.238 and mean diameter of 265 nm. Concentration at which aggregate formation starts was verified as 0.1% v/v with PI of 1.302 and particle mean diameter increasing to 480.1. Presence of a surfactant and non-volatile assay buffers signaled a need for sample cleaning. As a result, the use of solid-phase extraction (SPE) resources TARGA C-18 macroSpin TM columns and Bond Elut Omix tips in MtSK and PfTrxR assays respectively prior to LC-MS analysis was established.
MtSK inhibitory activity assay:
The MtSK inhibitory activity of EISO was evaluated using modified LC-MS-based functional assay [1] . A 500 µL total reaction in a microcentrifuge tube consisted of a test compound EISO and enzyme MtSK (0.2 µM) incubated for 30 min in 100 mM ammonium acetate buffer (pH 7.6) containing 50 mM MgCl 2 and 100 mM KCl. The reaction was initiated by addition of the substrates adenosine triphosphate (ATP, 1.2 mM) and shikimic acid (5 mM) and stopped after 30 seconds by the addition of 2 µL formic acid and immediately vortexed. Another experimental set had no preincubation and the reactions were started immediately. This was done to evaluate EISO for reversible (no preincubation) or non-reversible (preincubation) MtSk inhibition. The resulting sample after reaction quenching was then desalted through TARGA-C18 macroSpin TM columns (The Nest Group, Inc., Southborough, MA, USA). This was done by following the steps: 1) column conditioning by 100 µL acetonitrile (ACN); 2) equilibration with 100 µL LC-MS water; 3) Fifty micro liter sample loading and 4) elution by 50 µL of 80% methanol, 0.2% formic acid (FA). All the steps were separated by centrifuging at 8000 rpm for 1 min at 4 ˚C and the final eluate was injected into LC-MS. Initial MtSK inhibition was carried out at 0.01% and 0.1% v/v EISO. In determination of the 50% inhibitory concentration, EISO at 5-fold increasing concentrations of 0.0004%, 0.002%, 0.01%, 0.05% in Tween ® -20 was tested against MtSK at 0 minutes and 30 minutes preincubation. Highest Tween ® -20 concentration in the final reaction was 0.0004% v/v. Extent of inhibition was assessed by monitoring the production of shikimate 3-phosphate (S3P) and calculated in percentages by using the equation 100 x (control peak area -peak area in test compound presence)/control peak area. A dose-response curve was plotted using GraphPad Prism 5.02 software (Mountain View, CA, USA) and the IC 50 value was generated by the software. Control experiments (one without EISO and the other with Tween ® -20 in place of EISO) were performed the same way. The amount of S3P produced in the control samples without either EISO or Tween ® -20 was used to calculate the inhibition extent. All experiments including a control with Tween ® -20 were conducted in triplicates.
PfTrxR inhibitory activity assay:
The PfTrxR inhibitory activity of EISO was evaluated using a modified LC-MS-based functional assay [8b] . The EISO at concentration 0.01% v/v and 0.1% v/v in Tween ® -20 was tested against PfTrxR in this assay. Tween ® -20 concentration in the 300 µL final reaction was 0.0004%. EISO was incubated with 0.5 µM PfTrxR enzyme and 200 µM NADPH in 100 mM potassium phosphate buffer (pH 7.4) containing 2 mM EDTA. The enzymatic reaction was initiated by addition of a substrate 2.5 µM Trx-S 2 and incubated at room temperature for 30 min. The reaction was stopped by adding 2 µL of 0.1% formic acid diluted in the assay buffer. The reaction mixture was filtered through a 30 kDa MWCO ultrafiltration membrane centrifuged at 13000 rpm at 20 ˚C for 10 min. The enzyme was trapped on the membrane and product (Trx-(SH) 2 ) formed in the reaction was recovered in the filtrate. The filtrate was enriched and desalted by Bond Elut Omix pipet tips (Agilent Technologies, Santa Clara, CA, USA). This was carried out by adjusting the sample to 1% trifluoroacetic acid (TFA), tip stationary phase conditioning and equilibration with acetonitrile (ACN) and 1% TFA respectively. Sample was then aspirated and dispensed repeatedly making 7 cycles and a tip rinsed by 0.1%TFA. Eluate was then obtained from eluting with 70% ACN, 0.1% formic acid (FA) and analyzed by LC/MS. Control experiments (one without EISO and the other with Tween ® -20 in place of EISO) were percentages by using the equation 100 x (control peak area -peak area in test compound presence)/control peak area. Triplicate experiments were carried out.
LC-MS analysis:
An Agilent 1200 rapid resolution liquid chromatography (RRLC) system (Agilent Technologies, Santa Clara, CA, USA) coupled to the Accurate-Mass Q-TOF mass spectrometer 6520 was used in both assays: 1) S3P analysis: MtSKinhibitory assay was carried out using a 4.6 x 100 mm, 3.5 µm Phenyl-Hexyl column with a gradient mobile phase of 0.1% formic acid (FA) in water and acetonitrile. The gradient was run as follows: 2-30% B from 0-4min, 30-2% B from 4-6min and a 1 min post-run at 2 % B. Total gradient time was 6 min at column temperature of 40 ˚C. ESI negative mode and acquisition rate at 1 scan/s scanning from 100-1000 m/z was used. Direct inhibition of S3P production was monitored through relative peak areas. 2) Trx-(SH) 2 analysis: EISO PfTrxR-inhibitory activity was evaluated using a Narrow Bore Zorbax 300SB-C8 column, 2.1 x 100 mm, 3.5 µm and a gradient mobile phase of (A) 0.1% FA in water and (B) 0.1% FA in acetonitrile. A gradient mobile phase composition was 3-50% B from 0-4 min, 50-90% B from 4-10 min and 90% B for 2 min followed by a 2 min post-run. The total gradient time was 12 min at column temperature of 60 ˚C. The acquisition mode was positive electrospray ionization (+ESI) and rate was at 1 scan/s scanning from 300-3200 m/z. Inhibition of Trx-(SH) 2 
